Christopher L. Rinsch
46Patents
8h-index
34Co-inventors
75Inventor score
Filing activity: May 9, 1997 → Jan 19, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7449333B2 | Methods and compositions for tissue regeneration | Chemistry; Metallurgy | 23 | Expired |
| US7144729B2 | Methods and compositions for tissue regeneration | Chemistry; Metallurgy | 20 | Expired |
| US9872850B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 12 | Active |
| US5952226A | Hypoxia responsive EPO producing cells | Human Necessities | 11 | Expired |
| US8933217B2 | Compounds, compositions, and methods for protecting brain health in neurodegenerative disorders | Human Necessities | 11 | Active |
| US10485782B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 10 | Active |
| US10028932B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 9 | Active |
| US7879605B2 | Methods and compositions for tissue regeneration | Chemistry; Metallurgy | 8 | Active |
| US10857126B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 8 | Active |
| US9962366B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 7 | Active |
| US9994542B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 7 | Active |
| US10988453B2 | Compositions comprising an urolithin compound | Human Necessities | 7 | Active |
| US10442784B2 | Compositions comprising an urolithin compound | Human Necessities | 6 | Active |
| US11166937B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11234960B2 | Compositions and methods for improving mitochondrial function and treating neurodegenerative diseases and cognitive disorders | Emerging Cross-Sectional Technologies | 6 | Active |
| US11166972B2 | Compositions comprising nicotinamide riboside and a urolithin | Human Necessities | 6 | Active |
| US11020373B2 | Enhancing autophagy or increasing longevity by administration of urolithins or precursors thereof | Chemistry; Metallurgy | 5 | Active |
| US10695320B2 | Compositions comprising urolithin compounds | Chemistry; Metallurgy | 5 | Active |
| US10532992B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 5 | Active |
| US10792276B2 | Urolithins as immune response enhancers | Emerging Cross-Sectional Technologies | 5 | Active |
| US11180468B2 | Prodrugs of urolithins and uses thereof | Chemistry; Metallurgy | 4 | Active |
| US9394269B2 | Process-scale synthesis of urolithins | Human Necessities | 4 | Active |
| US7700351B2 | Methods and compositions for tissue regeneration | Chemistry; Metallurgy | 4 | Active |
| US8323638B2 | Methods and compositions for tissue regeneration | Chemistry; Metallurgy | 4 | Active |
| US9980980B2 | Compounds, compositions and methods for protecting brain health in neurodegenerative disorders | Human Necessities | 3 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.